Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial

  • Caren Sourij
  • , Abderrahim Oulhaj
  • , Faisal Aziz
  • , Norbert J. Tripolt
  • , Felix Aberer
  • , Peter N. Pferschy
  • , Marek Postula
  • , H. Drexel
  • , Martin Benedikt
  • , Ewald Kolesnik
  • , Thomas R. Pieber
  • , Heiko Bugger
  • , Dirk von Lewinski
  • , Harald Sourij

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1971-1975
Number of pages5
JournalDiabetes, Obesity and Metabolism
Volume26
Issue number5
DOIs
Publication statusPublished - May 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • N-terminal prohormone of brain natriuretic peptide
  • empagliflozin
  • myocardial infarction
  • prediabetes
  • sodium-glucose cotransporter 2 inhibitors
  • type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this